000 03361nab a2200433 c 4500
001 vtls000788285
003 RU-ToGU
005 20230131171352.0
007 cr |
008 201116|2018 si s a eng dd
024 7 _a10.1142/S1793545818500256
_2doi
035 _ato000788285
040 _aRU-ToGU
_brus
_cRU-ToGU
245 1 0 _aOptical in vivo and ex vivo imaging of glioma cells migration via the cerebral vessels: Prospective clinical application of the beta2-adrenoreceptors blockade for glioma treatment
_cO. Pavlova, A. Shirokov, A. Fomin [et al.]
336 _aТекст
337 _aэлектронный
504 _aБиблиогр.: 41 назв.
520 3 _aMalignant gliomas are highly invasive tumors that use the cerebral vessels for invasion due to high vascular fragility of the blood–brain barrier (BBB). On one hand, glioma is characterized by the BBB disruption, on the other hand, drug brain delivery via the BBB is a big challenge in glioma therapy. The limited information about vascular changes associated with glioma growth is a reason of slow progress in prevention of glioma development. Here, we present in vivo and ex vivo study of the BBB disruption and glioma cells (GCs) migration in rats using fluorescence and confocal microscopy. We uncovered a local breach in the BBB in the main tumor mass but not within the border of normal and malignant cells, where the BBB was impermeable for high weight molecules. The migration of GCs were observed via the cerebral vessels with the intact BBB that was associated with macrophages infiltration. The mechanisms underlying glioma progression remain unknown but there is an evidence that the sympathetic nervous system (SNS) via activation of vascular beta2-adrenoreceptors (B2-ADRs) can play an important role in tumor metastasis. Our results clearly show an increase in the expression of vascular B2-ADRs and production of the beta-arrestin-1 — co-factor of B2-ADRs signaling pathway in rats with glioma. Pharmacological blockade of B2-ADRs reduces the BBB disruption, macrophages infiltration, GCs migration and increases survival rate. These data suggest that the blockade of B2-ADRs may be a novel adjuvant therapeutic strategy to reduce glioma progression and prevent metastasis.
653 _aглиома
653 _aмакрофаги
653 _aгематоэнцефалический барьер
653 _aбета-аррестин
655 4 _aстатьи в журналах
_9745982
700 1 _aShirokov, Alexander
_9476778
700 1 _aFomin, Alexander
_9507041
700 1 _aNavolokin, Nikita A.
_9113427
700 1 _aTerskov, Andrey V.
_9497292
700 1 _aKhorovodov, Alexander P.
_9493742
700 1 _aNamykin, Anton A.
_9476775
700 1 _aPavlov, Alexey
_9311285
700 1 _aTuchin, Valery V.
_978712
700 1 _aSemyachkina-Glushkovskaya, Oxana V.
_9471534
700 1 _aPavlova, Olga
_9507042
773 0 _tJournal of innovative optical health sciences
_d2018
_gVol. 11, № 4. P. 1850025-1-1850025-10
_x1793-5458
852 4 _aRU-ToGU
856 4 _uhttp://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000788285
908 _aстатья
999 _c474476